Gemini Space Station, Inc. is rated Speculative Buy with a 12-month price target of $7–$8, despite a 90% post-IPO decline. GEMI's unique regulatory stack (DCM, DCO, FINRA) is valued near zero by the market, yet provides a competitive moat competitors cannot quickly replicate. Revenue grew 42% in Q1 2026 despite a 53% spot trading volume decline, with new products (prediction markets, equities, agentic trading) driving diversification.